AI Adoption Soars in Life Sciences as Researchers Weigh Efficiency Gains Against Trust and Training Barriers

Artificial Intelligence in Life Science: Survey Reveals Growing Use Amid Trust Concerns

A recent survey of 408 scientists and researchers worldwide highlights a significant increase in artificial intelligence (AI) adoption within life sciences. Despite more users integrating AI into their workflows, concerns about trust, training, and usability remain prominent. As budget pressures grow and efficiency becomes essential, the life science community is balancing AI's benefits with its limitations.

The study, part of BioInformatics' Beyond the Bench series, gathers insights from academic, government, and industry researchers. It shows how these professionals are assessing AI tools for tasks ranging from data analysis to experimental design.

Key Findings from the Survey

• Widespread adoption but mixed value: 87% of respondents use AI in their research, up from 75% in 2023. However, only 27% of frequent users feel AI delivers high value.
• Leading AI providers: Microsoft, Thermo Fisher Scientific, and Google DeepMind are the top organizations recognized for advancing AI in life sciences.
• Efficiency gains drive use: Faster data processing, improved throughput, and time savings are the main benefits cited by researchers.
• Barriers remain: Gaps in regulatory guidance, insufficient training, and organizational readiness limit AI’s full potential.

Concerns about data accuracy and cybersecurity risks also surfaced, reflecting hesitancy to fully trust current AI solutions in complex scientific environments.

These findings come at a critical time, as life science organizations seek quicker insights and operational improvements without compromising safety or reliability.

Industry Perspective

One expert involved in the survey emphasized that AI’s value depends heavily on usability and trust. Vendors need to focus on practical applications and user support to ensure adoption translates into meaningful outcomes.

About Beyond the Bench

Beyond the Bench is a free monthly report by BioInformatics that offers survey-based insights from over 55,000 life science professionals. It helps companies stay informed about shifts in customer sentiment and market priorities affecting product strategies and engagement.

About BioInformatics

BioInformatics, part of the Science and Medicine Group, is a market research and advisory firm serving life science and diagnostic sectors. Their research draws on a global panel of more than 55,000 professionals, providing data to support better, faster commercial decisions.

For researchers and teams looking to improve AI skills and integration, exploring targeted training resources can help bridge gaps in knowledge and readiness. Platforms like Complete AI Training offer courses designed for professionals aiming to enhance their AI expertise in scientific settings.